| Literature DB >> 29066844 |
Ling He1,2, Juan Zhong1,3, Qimei Gong1,2, Sahng G Kim4, Samuel J Zeichner5, Lusai Xiang1,2, Ling Ye3, Xuedong Zhou3, Jinxuan Zheng1,2, Yongxing Liu2, Chenyu Guan2, Bin Cheng6, Junqi Ling7, Jeremy J Mao8,9,10,11.
Abstract
Each year ~5.4 million children and adolescents in the United States suffer from dental infections, leading to pulp necrosis, arrested tooth-root development and tooth loss. Apical revascularization, adopted by the American Dental Association for its perceived ability to enable postoperative tooth-root growth, is being accepted worldwide. The objective of the present study is to perform a meta-analysis on apical revascularization. Literature search yielded 22 studies following PRISMA with pre-defined inclusion and exclusion criteria. Intraclass correlation coefficient was calculated to account for inter-examiner variation. Following apical revascularization with 6- to 66-month recalls, root apices remained open in 13.9% cases (types I), whereas apical calcification bridge formed in 47.2% (type II) and apical closure (type III) in 38.9% cases. Tooth-root lengths lacked significant postoperative gain among all subjects (p = 0.3472) or in subgroups. Root-dentin area showed significant increases in type III, but not in types I or II cases. Root apices narrowed significantly in types II and III, but not in type I patients. Thus, apical revascularization facilitates tooth-root development but lacks consistency in promoting root lengthening, widening or apical closure. Post-operative tooth-root development in immature permanent teeth represents a generalized challenge to regenerate diseased pediatric tissues that must grow to avoid organ defects.Entities:
Mesh:
Year: 2017 PMID: 29066844 PMCID: PMC5655000 DOI: 10.1038/s41598-017-14412-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Inclusion and exclusion criteria.
|
|
|---|
| • Human clinical studies assessing the treatment effect of apical revascularization on necrotic immature permanent teeth |
| • Apical revascularization or evoked bleeding was the primary treatment protocol besides disinfection and antibiotics use |
|
|
|
|
| • The abstract and title do not meet the inclusion criteria Review articles without new cases |
| • Non-human animal studies |
| • |
| • Endodontic treatment without apical revascularization or evoked bleeding |
| • Non-English |
|
|
| • No adjacent reference tooth or invisible reference anatomic locations |
| • No radiographic images provided or poor radiographic resolution* |
| • Post-operative follow-up < 6 months** |
| • Apical revascularization was performed in conjunction with orthodontic treatment |
*Unable to measure the cemento-enamel junction (CEJ), the most prominent incisal edge or cuspal edge or root apex, despite effort made by at least four clinically qualified coauthors and further verified by an oral and maxillofacial radiologist (S.J.Z.). **Elimination of one case with the concern of unfair disadvantage for apical revascularization due to insufficient postoperative time. The majority of the clinical cases had more than 6-month recalls.
Study IDs, patient demographics and self-reported peri-apical healing, apical closure, dental wall thickening and root lengthening.
| Patient # | PMID | Authors, year | Journal | Age | Sex | Treated tooth # | Reference tooth # | Disinfection | Intracanal medication | Coronal barrier/ sealing | Follow-up (months) | Author reported | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peri-apical healing | Apical closure | Dentin wall thickening | Root lengthening | ||||||||||||
| 1 | 15085044 | Banchs and Trope, 2004 | J Endod | 11 | M | 29 | 30 | 5·25% NaOCl, peridex | TAP | MTA, CR | 6, 12, 18 | Yes | Yes | Yes | Yes |
| 2 | 18571000 | Jung | J Endod | 10 | F | 20 | 21 | 2·5% NaOCl | TAP | MTA, CR | 12, 24 | Yes | Yes | Yes | Yes |
| 3 | 9 | F | 20 | 19 | 6, 24 | Yes | Yes | Yes | Yes | ||||||
| 4 | 14 | F | 29 | 28 | 12 | Yes | NR | NR | NR | ||||||
| 5 | 18634921 | Shah | J Endod | 16 | F | 10 | 9 | 2·5% NaOCl, 3% Hydrogen peroxide | FC | GIC | 6, 24 | Yes | Yes | Yes | Yes |
| 6 | 16 | F | 9 | 8 | 6 | Yes | Yes | Yes | Yes | ||||||
| 7 | 12 | F | 8 | 9 | 6 | Yes | Yes | Yes | Yes | ||||||
| 8 | 19125982 | Reynolds | 11 | F | 20 | 19 | 6% NaOCl, 2%CHX | TAP | MTA, CR | 18 | Yes | NR | NR | Yes | |
| 9 | Int Endod J | 11 | F | 29 | 30 | 18 | Yes | NR | NR | Yes | |||||
| 10 | 19410097 | Ding | J Endod | 8 | M | 9 | 8 | 5·25% NaOCl | TAP | MTA, CR | 10, 15 | Yes | Yes | Yes | NR |
| 11 | 19912384 | Shin | Int Endod J | 12 | F | 29 | 30 | 6% NaOCl, 2% CHX | None | MTA, CR | 7, 13, 19 | Yes | Yes | Yes | Yes |
| 12 | 20171379 | Petrino | J Endod | 11 | M | 29 | 30 | 5·25% NaOCl | TAP | MTA, CR | 12 | Yes | NR | Yes | Yes |
| 13 | 20 | 19 | 12 | Yes | NR | Yes | Yes | ||||||||
| 14 | 21133946 | Thomson | Aust Dent J | 12 | F | 20 | 21 | 1% NaOCl | TAP | MTA, GI, CR | 18 | Yes | NR | NR | Yes |
| 15 | 22077958 | Chen | Int Endod J | 8 | M | 29 | 28 | 5·25% NaOCl | Ca(OH)2 | MTA, CR | 7, 13 | Yes | Yes | Yes | NR |
| 16 | 10 | F | 20 | 19 | 9 | Yes | No | Yes | NR | ||||||
| 17 | 10 | M | 20 | 19 | 7, 26 | Yes | NR | Yes | NR | ||||||
| 18 | 22627612 | Kim | Int J Oral Sci | 12 | M | 20 | 19 | 3% NaOCl | TAP | MTA, GP, CR | 24 | Yes | Yes | Yes | NR |
| 19 | 10 | M | 29 | 28 | 42 | Yes | Yes | Yes | NR | ||||||
| 20 | 23146641 | Jadhav | J Endod | 18 | F | 9 | 8 | 2·5% NaOCl | TAP | GIC | 6, 12 | Yes | Yes | Yes | Yes |
| 21 | 16 | F | 9 | 8 | 6, 12 | Yes | Yes | Yes | Yes | ||||||
| 22 | 21 | M | 8 | 7 | 6, 12 | Yes | Yes | Yes | Yes | ||||||
| 23 | 15 | M | 9 | 10 | 6, 12 | Yes | Yes | Yes | Yes | ||||||
| 24 | 23 | M | 8 | 9 | 6, 12 | Yes | Yes | Yes | Yes | ||||||
| 25 | 23880282 | Shmizu | J Endod | 9 | M | 9 | 8 | 2·6% NaOCl | Ca(OH)2 | MTA, CR | 12 | Yes | NR | Yes | NR |
| 26 | 24041394 | Nosrat | J Endod | 8 | M | 8 | 9 | 2·5% NaOCl | Augmentin | MTA, CR | 17, 31 | Yes | Yes | Yes | No |
| 27 | 24332005 | Becerra | J Endod | 11 | F | 20 | 21 | 5·25% NaOCl | TAP | MTA, CR | 12 | Yes | Yes | Yes | No |
| 28 | 25443280 | Saoud | J Endod | 11 | M | 8 | 9 | 2·5% NaOCl | TAP | MTA, CR | 6, 9, 12 | Yes | Yes | Yes | NR |
| 29 | 25680956 | Nevins | J Endod | 14 | F | 13 | 12 | 6% NaOCl | DAP | GIC, CR | 6, 12 | Yes | Yes | NR | Yes |
| 30 | 25684914 | Narang | Contemp Clin Dent | * | * | 9 | 8 | 2·5% NaOCl | TAP | GIC, CR | 6, 18 | NR | NR | NR | NR |
| 31 | 25931029 | Lei | J Endod | 10 | F | 29 | 30 | 1% NaOCl | TAP | MTA, CR | 6, 10 | Yes | Yes | Yes | Yes |
| 32 | 26587419 | Park | Restor Dent Endod | 20 | F | 29 | 30 | 5·25% NaOCl | TAP | MTA, CR | 12 | Yes | Yes | NR | No |
| 33 | 10 | F | 29 | 30 | 12 | Yes | Yes | NR | No | ||||||
| 34 | 26647945 | Miltiadous | Braz Dent J. | 14 | M | 8 | 7 | 2·5% NaOCl | TAP | MTA, CR | 24, 36 | Yes | Yes | No | No |
| 35 | 26884781 | Khoshkhounejad | J Dent (Tehran) | 16 | M | 9 | 8 | 5·25% NaOCl, 0·2%CHX | TAP | MTA, CR | 6 | Yes | NR | NR | NR |
| 36 | 26949550 | She | Case Rep Dent | 12 | M | 4 | 5 | 3% NaOCl | Ca(OH)2 | MTA, CR | 7, 36, 66 | Yes | Yes | Yes | NR |
TAP: triple antibiotics paste; DAP: double antibiotics paste; GIC: glass ionomer cement; CR: composite resin; MTA: mineral trioxide aggregate; GP: gutta-percha; F: female; M: male; NR: not reported; Ca(OH)2: calcium hydroxide; NaOCl: sodium hypochlorite; FC: formocresol; CHX: chlorhexidine. *patients’ demographics provided as a group but not individually.
Figure 1PRISMA flow chart. PRISMA guidelines were strictly followed[19,20]. Out of 616 records emerged, duplicates removed to yield 320 full-length publications. Cases were excluded using pre-defined inclusion and exclusion criteria in Table 1. Titles and abstracts of the 320 full-length studies without reviewing any data in each report’s Result section, and excluded 268 studies to yield the resulting 52 studies. The full text of the 52 full-length reports were carefully reviewed to further exclude 30 studies, with specific reasons as stated, to yield the final 22 studies included in meta-analysis with a total of 36 clinical cases.
Figure 2Illustrated clinical cases of apical revascularization. Three cases illustrate not only representative clinical outcome and its diversity, but also intrinsic radiographic image distortion. The linear tooth-root length of the treated tooth (red lines); root lengths of the reference tooth (blue lines). In Case 1 (PMID 15085044), apical revascularization performed in the second mandibular premolar (P2) of an 11-year-old male patient (A), with 6-, 12- and 18-month recalls (B,C,D, respectively). Root-length ratios: 0.88, 0.90, 0.87 and 0.86. Apical closure at 18-month recall (D). Apical radiolucency resolved at 6-, 12- and 18-month recalls. In Case 2 (PMID 23146641), a necrotic central incisor of a 16-year-old female patient with arrested root-apex development (E) treated with apical revascularization and recalls at 6- and 12-months (F,G, respectively) with root-length ratios at 0.92, 0.93 and 0.94. Apical calcification bridge at both 6- and 12-month recalls (F,G). Modest apical radiolucency before treatment (E), but apparently became pronounced at 6- and 12-month recalls (F,G). In Case 3 (PMID 24332005), a necrotic second mandibular premolar of an 11-year-old female patient with arrested root-apex development (H) treated with apical revascularization, and 12-month recall (I). Root-length ratios at 0.77 to 0.88. No apparent apical closure at 12-month recall (I). Substantial pre-treatment apical radiolucency (H) resolved at 12 months (I).
Ratios of tooth-root length, apical width and root-dentin area before and after apical revascularization.
| Patient# | PMID | Recall (months) | Tooth-root length ratio | Apical width ratio | Root-dentin area ratio |
|---|---|---|---|---|---|
| 1 | 15085044 | 0 | 0·88 | 0·50 | 0·68 |
| 6 | 0·90 | 0·26 | 0·72 | ||
| 12 | 0·87 | 0·15 | 0·75 | ||
| 18 | 0·86 | 0·14 | 0·75 | ||
| 2 | 18571000 | 0 | 0·93 | 0·24 | 0·72 |
| 12 | 0·93 | 0·06 | 0·70 | ||
| 24 | 0·93 | 0·05 | 0·67 | ||
| 3 | 18571000 | 0 | 0·99 | 0·48 | 0·63 |
| 6 | 1·02 | 0·39 | 0·70 | ||
| 24 | 1·00 | 0·12 | 0·75 | ||
| 4 | 18571000 | 0 | 0·74 | 0·39 | 0·64 |
| 12 | 0·75 | 0·30 | 0·62 | ||
| 5 | 18634921 | 0 | 1·00 | 0·18 | 0·71 |
| 6 | 0·98 | 0·21 | 0·69 | ||
| 24 | 1·00 | 0·12 | 0·68 | ||
| 6 | 18634921 | 0 | 0·92 | 0·28 | 0·57 |
| 6 | 1·02 | 0·16 | 0·51 | ||
| 7 | 18634921 | 0 | 0·98 | 0·16 | 0·64 |
| 6 | 0·99 | 0·15 | 0·61 | ||
| 8 | 19125982 | 0 | 0·94 | 0·20 | 0·69 |
| 18 | 0·91 | 0·07 | 0·71 | ||
| 9 | 19125982 | 0 | 0·89 | 0·29 | 0·68 |
| 18 | 0·90 | 0·10 | 0·79 | ||
| 10 | 19410097 | 0 | 0·94 | 0·22 | 0·56 |
| 10 | 0·81 | 0·16 | 0·55 | ||
| 15 | 0·84 | 0·24 | 0·56 | ||
| 11 | 19912384 | 0 | 0·86 | 0·20 | 0·71 |
| 7 | 0·86 | 0·11 | 0·72 | ||
| 13 | 0·90 | 0·07 | 0·72 | ||
| 19 | 0·90 | 0·07 | 0·73 | ||
| 12 | 20171379 | 0 | 1·09 | 0·32 | 0·67 |
| 12 | 1·04 | 0·12 | 0·67 | ||
| 13 | 20171379 | 0 | 1·10 | 0·34 | 0·58 |
| 12 | 1·14 | 0·26 | 0·63 | ||
| 14 | 21133946 | 0 | 0·95 | 0·28 | 0·73 |
| 18 | 0·94 | 0·07 | 0·77 | ||
| 15 | 22077958 | 0 | 0·80 | 0·28 | 0·82 |
| 7 | 0·80 | 0·21 | 0·75 | ||
| 13 | 0·79 | 0·12 | 0·81 | ||
| 16 | 22077958 | 0 | 0·82 | 0·31 | 0·68 |
| 9 | 0·95 | 0·29 | 0·66 | ||
| 17 | 22077958 | 0 | 0·57 | 0·57 | 0·64 |
| 7 | 0·71 | 0·35 | 0·55 | ||
| 26 | 0·76 | 0·20 | 0·64 | ||
| 18 | 22627612 | 0 | 1·03 | 0·23 | 0·73 |
| 24 | 1·00 | 0·05 | 0·74 | ||
| 19 | 22627612 | 0 | 0·93 | 0·44 | 0·69 |
| 42 | 0·96 | 0·07 | 0·76 | ||
| 20 | 23146641 | 0 | 0·84 | 0·28 | 0·52 |
| 6 | 0·81 | 0·28 | 0·56 | ||
| 12 | 0·88 | 0·21 | 0·57 | ||
| 21 | 23146641 | 0 | 0·92 | 0·25 | 0·65 |
| 6 | 0·93 | 0·19 | 0·60 | ||
| 12 | 0·94 | 0·17 | 0·62 | ||
| 22 | 23146641 | 0 | 0·83 | 0·27 | 0·63 |
| 6 | 0·84 | 0·27 | 0·62 | ||
| 12 | 0·82 | 0·27 | 0·62 | ||
| 23 | 23146641 | 0 | 1·00 | 0·23 | 0·64 |
| 6 | 0·94 | 0·20 | 0·60 | ||
| 12 | 0·93 | 0·20 | 0·62 | ||
| 24 | 23146641 | 0 | 1·01 | 0·04 | 0·59 |
| 6 | 1·01 | 0·37 | 0·61 | ||
| 12 | 1·04 | 0·37 | 0·58 | ||
| 25 | 23880282 | 0 | 0·91 | 0·22 | 0·55 |
| 12 | 0·97 | 0·08 | 0·65 | ||
| 26 | 24041394 | 0 | 0·92 | 0·11 | 0·68 |
| 17 | 0·85 | 0·07 | 0·68 | ||
| 31 | 0·86 | 0·12 | 0·69 | ||
| 27 | 24332005 | 0 | 0·77 | 0·41 | 0·65 |
| 12 | 0·88 | 0·36 | 0·66 | ||
| 28 | 25443280 | 0 | 0·88 | 0·15 | 0·63 |
| 6 | 0·94 | 0·14 | 0·64 | ||
| 9 | 0·93 | 0·10 | 0·61 | ||
| 12 | 1·04 | 0·07 | 0·63 | ||
| 29 | 25680956 | 0 | 0·53 | 0·40 | 0·72 |
| 6 | 0·62 | 0·23 | 0·73 | ||
| 12 | 0·63 | 0·15 | 0·77 | ||
| 30 | 25684914 | 0 | 1·01 | 0·16 | 0·69 |
| 6 | 1·08 | 0·15 | 0·71 | ||
| 18 | 1·06 | 0·15 | 0·68 | ||
| 31 | 25931029 | 0 | 0·99 | 0·38 | 0·65 |
| 6 | 0·98 | 0·27 | 0·61 | ||
| 10 | 0·99 | 0·21 | 0·67 | ||
| 32 | 26587419 | 0 | 0·96 | 0·23 | 0·76 |
| 12 | 0·98 | 0·13 | 0·69 | ||
| 33 | 26587419 | 0 | 0·65 | 0·47 | 0·56 |
| 12 | 0·64 | 0·48 | 0·52 | ||
| 34 | 26647945 | 0 | 0·79 | 0·29 | 0·58 |
| 24 | 0·82 | 0·33 | 0·57 | ||
| 36 | 0·76 | 0·32 | 0·54 | ||
| 35 | 26884781 | 0 | 0·82 | 0·34 | 0·58 |
| 6 | 0·80 | 0·32 | 0·60 | ||
| 36 | 26949550 | 0 | 1·00 | 0·36 | 0·68 |
| 7 | 0·94 | 0·15 | 0·73 | ||
| 36 | 1·03 | 0·09 | 0·75 | ||
| 66 | 0·96 | 0·06 | 0·78 |
Figure 3Statistical analysis of tooth-root development following apical revascularization. (A) Tooth-root length ratios of all 36 included clinical cases revealing no significant postoperative root lengthening (p = 0.3472). (B) Apical width ratios of all 36 included clinical cases revealing significant postoperative narrowing of root apices (p < 0.0001), but this significance is restricted to types II and III cases, not type I patients (c.f. Supplemental Fig. 2B). (C) Root-dentin area ratios of all 36 included clinical cases revealing significant increase in postoperative root-dentin area (p = 0.0003), but this significance is restricted to types III cases, not type I and II patients (c.f. Supplemental Fig. 3B).
Figure 4Three types of apical development following apical revascularization. We divided root development of immature permanent teeth into three subgroups following therapeutic intervention, such as apical revascularization. Type I represents little or no postoperative apical narrowing, with open apices comparable to pre-intervention. Type I occurred in 5 of the included 36 cases at 13.9% (top diagram; also c.f. Supplemental Movie 1A). Type II represents apical calcification bridge formation, and occurred among 17 of the included 36 cases at 47.2% (middle diagram; also c.f. Supplemental Movie 1B). Type III represents apical closure to a degree similar to a fully mature tooth that has completed root development, and occurred among 14 of the included 36 cases at 38.9% (bottom diagram; also c.f. Supplemental Movie 1C).